A drug called Gefitinib Tablets IP are used to treat some cancers, particularly non-small cell lung cancer (NSCLC). They function by preventing certain signals that encourage cancer cells to grow and divide. They frequently cause gastrointestinal problems, skin rashes, acne-like skin eruptions, nausea, vomiting, and alterations in liver function tests as adverse effects. These tablets are produced utilizing top-notch components in a clean facility setting. These are well-liked in the market for their correct pH value, extended shelf life, non-hazardous nature, and safe usage. Additionally, we use excellent packing material to secure these Gefitinib Tablets IP to ensure their safety.